Syngeneic and allogeneic cell-mediated cytotoxicity against marek's disease lymphoblastoid tumor cell lines
- 15 February 1982
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 29 (2) , 187-194
- https://doi.org/10.1002/ijc.2910290213
Abstract
Cell-mediated cytotoxicity (CMC) of lymphocytes obtained from chickens infected with Marek's disease (MD) virus against allogeneic MD lymphoblastoid cell lines has been reported by several research groups. Recently, we established a number of cell lines from MD tumors obtained from highly inbred chickens and characterized for major and minor histocompatibility antigens. Allogeneic versus syngeneic CMC was studied using those cell lines and lymphocytes obtained from chickens 6-8 days post infection with 5B-1, a non-oncogenic MD virus. Allogeneic cytotoxicity could be easily demonstrated, while syngeneic cytotoxicity was a rare event. However, increase of the CMC assay period from 4 to 8 h did enhance syngeneic cytotoxicity. Cold inhibition assays demonstrated that the allogeneic cytotoxicity was directed against alloantigens present on spleen lymphocytes sharing the same major histocompatibility antigens as the target cells. Cytotoxicity was not influenced by the sex of either target or effector cells or by the level of virus infectivity of the effector cells.This publication has 23 references indexed in Scilit:
- Influence of Oncogenicity of Marek's Disease Virus on Evaluation of Genetic ResistancePoultry Science, 1981
- Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.The Journal of Experimental Medicine, 1979
- Alien histocompatibility antigens on tumor cellsImmunogenetics, 1979
- The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/gross murine leukemia virus antigensThe Journal of Experimental Medicine, 1979
- Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virusInfection and Immunity, 1978
- Characterization of an Apparently Nononcogenic Marek's Disease Virus23JNCI Journal of the National Cancer Institute, 1978
- Dissociation of Antiviral and Antitumor Immunity in Resistance to Marek's DiseaseJNCI Journal of the National Cancer Institute, 1977
- Cross‐protection between JMV Marek's disease‐derived tumour transplant, Marek's disease and Turkey herpesvirusesAvian Pathology, 1977
- Influence of Age at Exposure on the Pathogenesis of Marek's Disease 2JNCI Journal of the National Cancer Institute, 1973
- Specificity of Cellular Immune Reactivity to Virus-induced TumoursNature New Biology, 1972